PI3K signaling in arterial diseases: Non redundant functions of the PI3K isoforms

Adrien Lupieri1, Natalia Smirnova1, Nicole Malet1

  • 1INSERM, U1048, I2MC and Université Toulouse III, Toulouse, F-31300, France.

Insights

Phosphoinositide 3-kinase (PI3K) isoforms play key roles in cardiovascular diseases like atherosclerosis. Understanding PI3K functions in immune and arterial cells is crucial for developing targeted therapies against these common arterial pathologies.

Area of Science:

  • Cardiovascular biology and immunology
  • Molecular and cellular mechanisms of arterial disease

Background:

  • Cardiovascular diseases, including atherosclerosis, restenosis, and thrombotic complications, are leading global causes of mortality.
  • Arterial pathologies arise from complex interactions between immune and arterial cells, driving inflammatory and fibroproliferative responses.
  • Phosphoinositide 3-kinase (PI3K) signaling is increasingly recognized for its role in these cellular processes.

Purpose of the Study:

  • To review the diverse functions of phosphoinositide 3-kinase (PI3K) isoforms in cardiovascular disease.
  • To elucidate the specific roles of different PI3K isoforms in immune and arterial cells within the context of arterial pathologies.
  • To identify potential PI3K isoform targets for future therapeutic strategies in treating and preventing arterial diseases.

Main Methods:

  • Literature review focusing on PI3K isoform functions in cardiovascular and arterial cells.
  • Analysis of PI3K isoform expression, activation, and subcellular localization.
  • Synthesis of current understanding regarding PI3K's protective or detrimental effects in arterial disease models.

Main Results:

  • PI3K family comprises 8 members across classes I, II, and III, with distinct substrate specificities.
  • PI3K isoforms exhibit non-redundant functions due to differential expression, activation, and localization.
  • Specific PI3K isoforms are implicated in both protective and deleterious effects within immune and arterial cells.

Conclusions:

  • Targeting specific PI3K isoforms holds promise for novel therapeutic interventions in cardiovascular diseases.
  • Further research is needed to precisely delineate the roles of each PI3K isoform in arterial disease pathogenesis.
  • Selective inhibition or activation of PI3K isoforms may offer a strategy to manage atherosclerosis and its complications.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
16.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.6K